A novel assay to detect nucleotide receptor P2X7 genetic polymorphisms influencing numerous innate immune functions

Loren C Denlinger1, Kathleen Schell, Giuditta Angelini

  • 1Departments of Medicine and Biomolecular Chemistry, University of Wisconsin Medical School, Madison, Wisconsin 53792, USA. ldenling@wisc.edu

Insights

Genetic variations in the P2X7 receptor influence inflammatory responses to lipopolysaccharide (LPS). Our study developed a novel monocyte pore assay to analyze these P2X7 alleles and their impact on cytokine production, revealing P2X7

Area of Science:

  • Immunology
  • Genetics
  • Cell Biology

Background:

  • Accessory signaling pathways amplify endotoxin (lipopolysaccharide, LPS) responses.
  • Genetic studies reveal LPS-hyporesponsive individuals despite common TLR4 alleles.
  • The nucleotide receptor P2X7 modulates LPS-stimulated inflammatory mediator production.

Purpose of the Study:

  • To describe the largest phenotypic screen for genetic polymorphisms in the P2X7 receptor.
  • To develop a novel monocyte pore assay for rapid, multiplex analysis of clinical samples.
  • To investigate how P2X7 alleles modulate LPS-stimulated cytokine production.

Main Methods:

  • Development of a novel monocyte pore assay.
  • Phenotypic screening of genetic polymorphisms in P2X7.
  • Analysis of LPS-stimulated cytokine production.

Main Results:

  • P2X7 alleles were identified as modulators of LPS-stimulated cytokine production.
  • The novel monocyte pore assay allows for rapid (<3h) multiplex analysis.
  • Genetic variations in P2X7 impact innate immune responses.

Conclusions:

  • P2X7 receptor genetic polymorphisms significantly influence innate immune responses to LPS.
  • The developed monocyte pore assay is a valuable tool for clinical sample analysis.
  • P2X7 may function as an amplification loop in innate immunity.

Related Concept Videos